Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 1—January 2007

Research

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 4

Multivariable analysis of discordant versus concordant empiric antimicrobial drug therapy in patients with multidrug-resistant Acinetobacter infections, Baltimore hospitals, 2003–2004*

Outcome evaluatedDiscordant vs. concordant empiric antimicrobial drug therapy†
OR (95% CI)p value
Length of stay, d1.6 (0.4–6.5)0.54
Intensive care unit length of stay, d5.8 (1.2–27.1)0.03
Mortality rate (%)0.7 (0.1–4.5)0.74

*OR, odds ratio; CI, confidence interval.
†Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO